Your browser doesn't support javascript.
loading
Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning.
Tordai, Attila; Bors, Andras; Kiss, Katalin Piroska; Balassa, Katalin; Andrikovics, Hajnalka; Batai, Arpad; Szilvasi, Aniko; Rajczy, Katalin; Inotai, Dora; Torbagyi, Eva; Lengyel, Lilla; Barta, Aniko; Remenyi, Peter; Masszi, Tamas.
Afiliação
  • Tordai A; Laboratory of Molecular Diagnostics, Hungarian National Blood Transfusion Service, Budapest, Hungary.
  • Bors A; Department of Pathophysiology, Semmelweis University, Budapest, Hungary.
  • Kiss KP; Laboratory of Molecular Diagnostics, South-Pest Central Hospital-National Institute of Haematology and Infectology, Budapest, Hungary.
  • Balassa K; Laboratory of Molecular Diagnostics, Hungarian National Blood Transfusion Service, Budapest, Hungary.
  • Andrikovics H; Laboratory of Molecular Diagnostics, Hungarian National Blood Transfusion Service, Budapest, Hungary.
  • Batai A; Laboratory of Molecular Diagnostics, Hungarian National Blood Transfusion Service, Budapest, Hungary.
  • Szilvasi A; Laboratory of Molecular Diagnostics, South-Pest Central Hospital-National Institute of Haematology and Infectology, Budapest, Hungary.
  • Rajczy K; Department of Haematology and Stem Cell Transplantation, South-Pest Central Hospital-National Institute of Haematology and Infectology, Budapest, Hungary.
  • Inotai D; Transplantation Immunogenetics Laboratory, Hungarian National Blood Transfusion Service, Budapest, Hungary.
  • Torbagyi E; Hungarian Stem Cell Donor Registry, Hungarian National Blood Transfusion Service, Budapest, Hungary.
  • Lengyel L; Transplantation Immunogenetics Laboratory, Hungarian National Blood Transfusion Service, Budapest, Hungary.
  • Barta A; Department of Haematology and Stem Cell Transplantation, South-Pest Central Hospital-National Institute of Haematology and Infectology, Budapest, Hungary.
  • Remenyi P; Department of Haematology and Stem Cell Transplantation, South-Pest Central Hospital-National Institute of Haematology and Infectology, Budapest, Hungary.
  • Masszi T; Department of Haematology and Stem Cell Transplantation, South-Pest Central Hospital-National Institute of Haematology and Infectology, Budapest, Hungary.
PLoS One ; 14(6): e0218945, 2019.
Article em En | MEDLINE | ID: mdl-31237928
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Sangue / Antígenos HLA-C / Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Condicionamento Pré-Transplante / Receptores KIR Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Hungria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Sangue / Antígenos HLA-C / Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Condicionamento Pré-Transplante / Receptores KIR Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Hungria